
Moderna (MRNA) Stock Down 0.3% on Disputes with U.S. Scientists over COVID-19 Vaccine Trials
Moderna (MRNA) stock recently plunged over reported disagreements with government scientists about the company’s vaccine trial process. Today in the pre-market, the stock price is around $60.90.